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Mitral stenosis (MS) after mitral valve (MV) repair is a slowly progressive condition, usually 
detected many years after the index MV surgery. It is defined as a mean transmitral pres-
sure gradient (TMPG) >5 mmHg or a mitral valve area (MVA) <1.5 cm2. Pannus formation 
around the mitral annulus or extending to the mitral leaflets is suggested as the main 
mechanism for developing delayed MS after MV repair. On the other hand, early stenosis 
is thought to be a direct result of an undersized annuloplasty ring. Furthermore, in MS 
following ischemic mitral regurgitation (MR) repair, subvalvular tethering is the hypothe-
sized pathophysiology. MS after MV repair has an incidence of 9–54%. Several factors 
have been associated with a higher risk for developing MS after MV repair, including the 
use of flexible Duran annuloplasty rings versus rigid Carpentier–Edwards rings, complete 
annuloplasty rings versus partial bands, small versus large anterior leaflet opening angle, 
and anterior leaflet tip opening length. Intraoperative echocardiography can measure the 
anterior leaflet opening angle, the anterior leaflet tip opening dimension, the MVA and the 
mean TMPG, and may help identify patients at risk for developing MS after MV repair.
Keywords: functional mitral stenosis, iatrogenic mitral stenosis, mitral valve repair surgery, intraoperative 
echocardiography, annuloplasty
inTRODUCTiOn
The mitral valve (MV) complex plays a crucial role in cardiac function, controlling blood flow 
between the left atrium and the left ventricle. The components of the MV complex include an anterior 
leaflet, a posterior leaflet, tendinous chords, papillary muscles, and a saddle-shaped annulus at the 
atrioventricular junction (1). Deviation in the morphology of any of these components may result 
in compromised mechanical integrity of the MV complex, and abnormal leaflet coaptation (1). With 
studies suggesting that the MV is an active, dynamic structure that is susceptible to treatment, it is 
imperative to understand the types of diseases associated with these functional changes (2).
Mitral stenosis (MS) following MV repair surgery for non-rheumatic regurgitant MV disease is 
a pathology that is poorly understood. Currently, functional MS is defined as a mean transmitral 
pressure gradient (TMPG) >5 mmHg or a mitral valve area (MVA) <1.5 cm2 irrespective of the 
etiology (3, 4). Patients fall into two main categories; MS following ischemic mitral regurgitation 
(MR) repair or MS after degenerative MR repair. The occurrence of MS after MV repair is not well 
studied despite its relatively high incidence ranging from 9 to 54% (4–6). Furthermore, the impact 
of perioperative echocardiography on this condition is not clear (7). The 2014 ACC/AHA guidelines 
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state that echocardiography should be used intraoperatively to 
guide MV repair and to ensure MV patency and correction of 
MR. However, the guidelines are based on studies of patients in 
the outpatient setting and make no comment of the potential 
detrimental effect of post-cardiopulmonary bypass (CPB) hemo-
dynamic derangements on echocardiographic parameters (8). 
Consequently, patients may return a few years later after having 
improved in functional status following MV repair with newly 
developed MS (9). Therefore, it is vital to identify intraoperative 
echocardiographic parameters that may predict whether or not a 
patient will develop MS after MV repair surgery.
A few studies have investigated the development of MS after 
MV repair with conflicting results. Furthermore, a majority of the 
studies focused on the postoperative diagnosis of this condition 
without any mention of potential intraoperative contributing fac-
tors (10, 11). However, the identification of possible intraopera-
tive predictors may be vital to patient outcomes. This article aims 
to provide an overview of the occurrence of MS after open MV 
repair surgery for regurgitant valves, its epidemiology, and risk 
factors. Likewise, we emphasize the role of the anesthesiologist 
in identifying intraoperative echocardiographic indices that may 
predict future development of MS. Our review excludes patients 
with rheumatic heart disease, patients with MS as the indication 
for MV surgery, and patients undergoing percutaneous MV 
repair.
eTiOLOGY
Different mechanisms may lead to the occurrence of early or 
delayed MS after MV repair. These variables can be related to the 
surgical technique utilized for the repair (5). Early functional MS 
after MV repair was thought to be a direct result of the restrictive 
annuloplasty, since the elevated TMPGs are noticed early after 
the repair (4, 9). Repair surgery for degenerative MR involves 
resection of parts of the posterior leaflet, plication, and sliding. 
An annuloplasty ring or band is then placed to support the repair. 
Resection of the redundant leaflet tissue and the undersized rings 
may reduce the MV area and restrict its opening, resulting in 
obstruction at the levels of the annulus and leaflets (9).
Subvalvular tethering was suggested as a possible mechanism 
of functional MS following ring annuloplasty for ischemic MR 
in particular. This tethering restricts leaflet opening, and the 
annuloplasty ring reduces annular size and, consequently, further 
restricts MV opening, resulting in significant functional MS (12).
In cases of late fibrous tissue growth on the annuloplasty 
rings, pannus formation, as a possible foreign body reaction, was 
suggested as the cause of MS. Histopathological examination in 
such cases revealed giant cells containing intracytoplasmic ring 
material (13).
RiSK FACTORS
In 2002, Ibrahim and David published the first report in 4 out 
of 518 patients (14). The initial pathology for which the patients 
underwent MV repair was ischemic MR in two cases and 
degenerative MR in the other two cases. One interesting finding 
was that all four patients received a Duran ring annuloplasty for 
the initial repair. The MVA decreased in all patients from the 
preoperative value by 52–82%. Due to the symptomatic severe 
stenosis, the MV had to be replaced in three of the four patients, 
while the last patient had mild symptoms despite the low MVA 
(1.2 cm2) and needed no further intervention. Upon reoperation, 
extensive fibrous tissue was discovered on the annuloplasty ring. 
The pannus extended to the MV leaflets that became stiff, result-
ing in a narrowed opening (14).
In the years that followed, several reports were published on 
late MS due to pannus formation after MV regurgitation repair 
(13, 15–20). In most of these reports, MS developed after using a 
flexible Duran annuloplasty ring, with only one case developing 
with a rigid ring (17). In most cases, further echocardiographic 
assessment revealed that the MV leaflets were morphologically 
normal and the fibrous tissue predominantly formed at the level 
of the annuloplasty ring (18). In Nishida’s report, the fibrous tissue 
covered the Duran ring and also extended to the leaflets, which 
became stiff and immobile (16). Although this condition was 
often reported to develop in Duran ring recipients, the sporadic 
occurrence of such cases made the evaluation of risk factors very 
difficult (13, 15–20).
A recently published retrospective study compared a group 
of patients, mostly with degenerative MR, who received a Duran 
ring annuloplasty to another group that received a Carpentier–
Edwards (CE) ring annuloplasty (21). The researchers found that 
the patients with the flexible Duran ring had significantly smaller 
MVA and higher mean TMPGs, resulting in a higher incidence of 
functional MS. Interestingly, Duran ring recipients experienced a 
gradual annual increase in mean TMPG at a rate of 0.19 mmHg/
year, which was not experienced by the patients with the rigid CE 
ring. Significant pannus formation around the MV annulus could 
be detected on cardiac computed tomography (CT) and was sig-
nificantly higher in the Duran ring patients, whereas the leaflet 
thickness was not different between the two groups, confirming 
that the obstruction was at the level of the annulus, and possibly 
caused by the pannus formation. These findings may indicate that 
MS after MV repair is a progressive process that starts early after 
the repair (21).
One explanation for the higher incidence of functional MS in 
Duran ring recipients is that Duran rings tend to be smaller than 
other ring types. Furthermore, the selection of Duran ring size is 
based on intertrigonal dimension, whereas for Carpentier rings, 
the selection is based on the intercommisural dimension, which 
is larger than the intertrigonal dimension (15, 20). Duran rings 
also have a circular non-physiological shape, which can alter the 
normal saddle shape of the mitral annulus (22). Additionally, the 
templates used to deliver Duran rings require excessive contact 
around the valve and may result in injury to the leaflets (15, 18).
Effective orifice area indexed to body surface area (EOAi) 
<0.9 cm2/m2 defines severe prosthesis-patient mismatch (PPM) 
after MV replacement, where the effective orifice area of the 
prosthetic valve is too small for the patient (23). Functional MS 
after MV repair may mimic PPM after MV replacement (3, 4). 
In a recent publication, Bertrand et al. observed an increase in 
EOAi during exercise in patients who underwent restrictive 
annuloplasty. An EOAi of >0.9cm2/m2, with exercise and not at 
rest, proved to be an independent predictor of functional capacity 
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and outcome. The anterior leaflet opening angle (α) at peak exer-
cise was the strongest determinant of EOAi (3).
In 2010, Kubota et al. (12) found that the anterior MV leaflet 
opening angle was an independent contributor to the leaflet tip 
opening length, which in itself, was an independent contributor 
to the MVA after repair. Although they did not offer any recom-
mendations, the results showed a decrement in the opening 
angle from 68 ± 7 preoperatively to 62 ± 9 postoperatively and 
a decrease in the anterior leaflet tip opening dimension from 
1.5  ±  0.2  cm preoperatively to 1.0  ±  0.3  cm postoperatively 
(p < 0.05). This was associated with an incidence of functional 
MS of approximately 42%. However, the findings in this study 
during exercise were against those of Bertrand’s. Although the 
annular size did not change, the mean and the peak TMPGs 
were significantly increased by exercise, whereas the MVA was 
significantly reduced. This reduction was attributed to further 
restriction of the anterior leaflet opening angle and the leaflet 
tip opening dimension (12). The role of post-CPB intraoperative 
EOAi and α-angle is still to be determined.
inTRAOPeRATive DiAGnOSTiCS
In the light of the aforementioned findings, it is crucial to identify 
the possibility of functional MS intraoperatively. Intraoperative 
echocardiographic assessment should ensure patency and rule out 
any restriction to the diastolic movement of the MV leaflets or any 
atrial flow convergence zone during diastole (24). The 2014 ACC/
AHA guidelines recommend the use of 2D-planimetry, TMPG 
and pressure half-time (PHT) for the assessment of native MV 
area to establish the diagnosis, determine the severity, and guide 
the treatment of MS (8). However, there is a lot of controversy 
surrounding post-repair assessment of the MVA. The guidelines 
do not specify how to assess the MV during or after repair surgery 
to prevent a newly established MS.
The non-planar saddle shape of the mitral annulus plays an 
important role in the normal functioning of the MV. Mitral valve 
repair and placement of an annuloplasty ring may cause morpho-
logical changes to the annulus. Flat annuloplasty rings were found 
to increase the non-planarity angle (NPA), and thus making the 
annulus less non-planar, whereas the saddle-shaped rings were 
found to decrease the NPA and increase the non-planarity of 
the annulus (25). The innate non-planarity of the valve makes 
it hard to delineate the entire margin of the valve leaflets, and 
the morphological change after repair surgery further limits the 
ability of 2D-planimetry to assess the MVA (26, 27).
Nonetheless, in Maslow et al.’s report, MVA quantification by 
2D-planimetry (1.0 cm2) and PHT (1.29 cm2) was consistent with 
MS, whereas peak TMPG was low (6 mmHg). Direct measure-
ment of the gradient by inserting a needle into the left atrium 
and the left ventricle confirmed the presence of a high TMPG 
gradient of 16  mmHg, which prompted immediate revision of 
the valve (27).
On the other hand, Riegel et al. proposed that an intraoperative, 
post-CPB peak TMPG >17 mmHg or a mean TMPG >7 mmHg 
were suggestive of a clinically relevant iatrogenic MS that requires 
reoperation following MV repair. In their study, intraoperative 
MVA by PHT could not reliably predict the need for reoperation 
(28). The limitation of the PHT use is supported by other studies 
showing that echocardiography using PHT immediately after 
repair underestimates the measurement of MVA, creating a chal-
lenge when taking decisions regarding low estimated MVA. PHT 
is related not only to the MVA but also to the left ventricular and 
left atrial compliance and the flow and pressure gradients across 
the MV. Therefore, a change in transmitral blood flow, pressures, 
or chamber compliances after surgery may contribute to the 
measured PHT value, and may overestimate a non-significant 
MS (29).
After demonstrating the importance of MVA follow-up when 
predicting functional capacity (9), Chan et al. published another 
research paper looking at intraoperative TMPGs and MVA (30). 
They found that intraoperative mean and peak TMPGs were 
lower, and the planimetered MVAs were higher than the follow-
up resting values (p < 0.05). However, their results showed that 
only intraoperative mean TMPGs, and not intraoperative MVAs, 
could predict the postoperative TMPG values. Furthermore, 
they proposed a linear correlation between intraoperative 
mean TMPGs (x) and follow-up mean TMPGs (y) as follows: 
(y  =  1.8  +  0.86x). Their findings suggested that post-repair 
functional MS was predictable by an intraoperative mean TMPG 
value of >4 mmHg (30). Nonetheless, some studies argue against 
using TMPGs after repair surgery to make a diagnosis, as they 
are dependent on several variables and showing poor correlation 
with MVA (27, 31).
POSTOPeRATive FUnCTiOnAL 
iMPLiCATiOnS
MS after ischemic Mitral Regurgitation 
Repair
Most patients will experience improvement of their symptoms 
after MR repair, and the presence of a mild MS might not be 
recognized by the patient initially (4, 9). Magne et  al. studied 
patients undergoing MV repair and CABG for ischemic MR (10). 
There was a significant increase in the postoperative mean and 
peak TMPGs (p < 0.001) and systolic pulmonary artery pressure 
(PAP) values (p < 0.008) compared to the preoperative measure-
ments (10). When the study patients were compared to a control 
group of coronary artery disease patients without significant 
preoperative MR, the mean TMPGs and PAP were found to be 
significantly higher in the annuloplasty group both at rest and 
during a dobutamine stress test (p <  0.05). The annuloplasty 
group also had significantly smaller MV effective orifice areas 
(EOA) postoperatively (p  <  0.05). This group also showed a 
significant reduction in 6-minute walking test (6MWT) distance 
13 ± 3 months postoperatively. Furthermore, 54% of the annu-
loplasty patients had a postoperative MVA <1.5 cm2 and a mean 
TMPG >5 mmHg. The PAP and exercise TMPG findings in the 
annuloplasty group were similar to those found in patients with 
moderate-to-severe MS. The authors concluded that the findings 
suggested functional MS development after MV annuloplasty, and 
that this MS resulted in reduced patient functional capacity (10).
Rubino et  al. found different results when they compared 
patients with ischemic MR who had post-repair mean TMPGs 
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>5 versus <5 mmHg 9 months postoperatively (11). Although 
approximately 50% of the patients showed at least mild MS post-
surgery, the two groups were not significantly different in long-
term freedom of hospitalization, freedom of congestive heart 
failure, and 23-month survival. Contrary to Magne’s paper, which 
found smaller MVA in the group with higher TMPGs, Rubino 
et al. found that there was no difference in MVA between the two 
groups. The authors concluded that functional MS induced by 
restrictive annuloplasty was well tolerated by the patients and did 
not impact patient survival or functional capacity (11).
These findings were further supported by another study, 
showing that after MV repair for ischemic MR, mean TMPGs 
>5 mmHg did not adversely affect patient survival (5). On the 
contrary, it was discovered that mean TMPGs >5 mmHg were 
associated with a higher maximum oxygen uptake, a higher car-
diac output (CO), and an increase in exercise capacity. They pro-
posed that TMPGs in patients with previous ischemic MR should 
be read in light of CO and LV function values; a high TMPG in 
the presence of a normal CO might be acceptable, whereas low 
TMPGs may mask a significant MS in a low CO patient (5).
MS after Degenerative Mitral 
Regurgitation Repair
Chan et  al. compared patients undergoing annuloplasty for 
degenerative MR, with high postoperative resting TMPGs to a 
control group with low resting TMPGs (9). They found that the 
group with the higher gradients also had significantly higher left 
atrial volumes at rest (p = 0.02) and smaller calculated MVA on 
echocardiography. The PAP also was higher both at rest and peak 
exercise in the high gradient group (p = 0.02) and correlated with 
the resting mean TMPG. Their findings were consistent with a 
functional MS and multivariable analysis showed that MVA was 
an independent predictor of exercise capacity (9).
Mesana et  al. found similar results when they compared 
patients who received partial band annuloplasty to patients 
who received a complete ring annuloplasty (32). In that study, 
patients who underwent annuloplasty using the complete ring 
had higher postoperative mean TMPGs both at rest and exercise 
(p < 0.0001 and p = 0.0002, respectively). They also had higher 
right ventricular systolic pressures both at rest (p = 0.003) and 
peak exercise (p =  0.004), greater indexed left atrial volumes 
(p <  0.001), and smaller MVA (p <  0.001). The difference in 
mean TMPGs between the two groups was even more prominent 
at peak exercise. On functional assessments, patients with a 
complete ring annuloplasty reported lower overall general 
health (p = 0.007) and energy levels compared to partial band 
patients (p = 0.02). This study faces a noteworthy limitation that 
requires further investigation. The complete ring group was a 
mix of patients who were randomly assigned to receive either a 
Duran ring or a CE ring. The difference between the two groups 
might be attributable to the higher risk of MS associated with 
Duran rings, and not the fact that the rings were complete or 
partial (32).
COnCLUSiOnS
Mitral stenosis after MR repair surgery is a problem that originates 
from the time of surgery and progresses over time. It is usually 
not detected before the patient leaves the operating room due to 
the lack of adequate studies and guidelines that can help diagnose 
this problem intraoperatively. Most patients with severe MR who 
live sedentary lives will improve after the repair and tolerate 
the increased TMPGs and narrowed MVA without developing 
symptoms for many years. Young individuals often undergo MV 
repair to benefit from the functional improvement that surgery 
offers and avoid future complications. Therefore, MV repair 
surgery should never trade regurgitation for a new stenosis. 
The collaboration between the cardiac surgeon performing the 
procedure and the anesthesiologist monitoring the intraopera-
tive variables is paramount. Based on the current literature, no 
strong recommendations can be drawn regarding early predic-
tion. Future studies should recognize and validate the red flags 
that indicate which individuals are at a higher risk for developing 
MS. Intraoperative post-CPB echocardiographic assessment of 
the anterior leaflet opening angle and opening dimension, accu-
rate measurement of MVA, and possible changes to the surgical 
techniques may prove beneficial. Cardiac anesthesiologists are 
encouraged to consider establishing specific guidelines that can 
help prevent MS after repair surgery for MR patients.
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